The store will not work correctly when cookies are disabled.
3-(6-((methylamino)methyl)-1H-indol-3-yl)benzothioamide
ID: ALA4547128
PubChem CID: 132137173
Max Phase: Preclinical
Molecular Formula: C17H17N3S
Molecular Weight: 295.41
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: CNCc1ccc2c(-c3cccc(C(N)=S)c3)c[nH]c2c1
Standard InChI: InChI=1S/C17H17N3S/c1-19-9-11-5-6-14-15(10-20-16(14)7-11)12-3-2-4-13(8-12)17(18)21/h2-8,10,19-20H,9H2,1H3,(H2,18,21)
Standard InChI Key: AOIMBJBYHPHQKN-UHFFFAOYSA-N
Molfile:
RDKit 2D
21 23 0 0 0 0 0 0 0 0999 V2000
10.7995 -3.6484 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.7984 -4.4680 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.5064 -4.8769 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.2161 -4.4675 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.2133 -3.6448 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.5047 -3.2396 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.9194 -3.2336 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.6287 -3.6395 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
11.5062 -5.6941 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.9164 -2.4164 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
10.8474 -6.1706 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.0997 -6.9479 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
12.1695 -6.1709 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.9180 -6.9445 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.4617 -7.5470 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.2570 -7.3772 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.5057 -6.5995 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.9603 -6.0003 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.8055 -7.9830 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.5551 -8.7609 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
14.1036 -9.3667 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
5 7 1 0
7 8 1 0
3 9 1 0
7 10 2 0
9 11 2 0
11 12 1 0
12 14 1 0
13 9 1 0
13 14 2 0
14 15 1 0
15 16 2 0
16 17 1 0
17 18 2 0
18 13 1 0
16 19 1 0
19 20 1 0
20 21 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 295.41 | Molecular Weight (Monoisotopic): 295.1143 | AlogP: 3.19 | #Rotatable Bonds: 4 |
Polar Surface Area: 53.84 | Molecular Species: BASE | HBA: 2 | HBD: 3 |
#RO5 Violations: ┄ | HBA (Lipinski): 3 | HBD (Lipinski): 4 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 12.69 | CX Basic pKa: 9.42 | CX LogP: 3.02 | CX LogD: 1.02 |
Aromatic Rings: 3 | Heavy Atoms: 21 | QED Weighted: 0.65 | Np Likeness Score: -0.34 |
References
1. (2017) Ash1l inhibitors and methods of treatment therewith, |